Type of Services: Simultaneous Interpretation service and equipment
Language: English to French AND French to English
Expected Dates: 8th -9th December 2022
Venue: Kigali, Rwanda
Application Deadline: November 28, 2022, at 12.00 pm Addis time
The African Constituencies Bureau (ACB) for the Global Fund was established by a resolution of African Health ministers in 2012. The ACB, also known as the Bureau, brings together the two African Constituencies West and Central Africa (WCA) and East and Southern Africa (ESA) represented at the Global Fund (GF)to fight HIV/AIDS, Tuberculosis and Malaria. The two constituencies represent 47 African countries that are recipients of GF support for HIV, TB and Malaria control. The Bureau facilitates collaboration across the two constituencies, facilitates effective engagement, representation and participation of the two constituencies in GF processes as well as enhancing their capacity to shape GF policies and processes. It also ensures that Africa’s voice is enhanced to influence Global Health policy decisions.
Background to NextGen Market Shaping
Africa’s imports of medical products and commodities consumed in Africa account for over 70%, and worth around $14 billion annually. In the Global Fund’s current funding cycle (i.e. 2022-2022), Africa received commodities valued at USD 6.9 billion, mostly imported from abroad through Global Fund support. With the onset of the COVID-19 pandemic, Africa’s ability to quickly respond with essential therapeutics and personal protective equipment (PPEs) was significantly hampered as these have historically been sourced from abroad. Further, even when vaccines, rapid tests kits and treatments were developed in the Global North at record speed, these could not reach many Africans in a timely manner. The continent was relegated to the backline of life saving health commodities, with the result that most commodities had short shelf life by the time they landed on the continent. COVID-19 has therefore taught Africa it cannot continue the path of dependence of health commodities from abroad to secure the health of its population.
Africa is a major recipient of Global Fund resources. In February 2022, The Global Fund finalized its outline/framework for the NextGen Market Shaping (NMSF) to align to the ambition set out in the Global Fund’s 2023-2028 Strategy to end HIV, TB and Malaria. The NextGen Market Shaping Strategy hopes in part to address Africa’s dependence on imports through local manufacturing through capacity building. The Framework is focused on developing interventions with the goal of achieving equitable access to quality assured health products and services while ensuring :
Discussions on reducing Africa’s dependence on imports and shaping markets to work are not new. They date back as far as the Abuja Summit in 2001. The rallying call to boost local manufacturing continues to grow and has now been made even more critical based on lessons learned from the COVID-19 pandemic. To keep the conversations and actions going, the African Constituency Bureau (ACB) for the Global Fund in collaboration with a variety of stakeholders including the African Union, WHO, AU-NEPAD, the Global Fund and African governments will gather experts on market shaping / local manufacturing on 8-9 December, 2022, in Kigali, Rwanda, ahead of the Conference on Public Health in Africa (CPHIA) conference to take stock of progress made on local manufacturing, explore prospects and cost-benefits, find ways to address impending challenges, recalibrate existing roadmaps and keep political will for the initiatives high and on the continental agenda.
Qualified providers will provide the following services: